biomarkers & Genomics
I believe healthcare technology can connect people, improve care and deliver better patient outcomes.
challenge the status quo
I see opportunites where others see roadblocks. Let's work together.
Naturally persuasive and articulate in presentation, I am an idea generator. Building a brand's identity, developing marketing messaging and compassionately understanding the needs of patients and physicians in ways that improve healthcare value all energize me.
COMMITTED TO IMPROVING HEALTHCARE VALUE
Liz Cramer is an oncology molecular diagnostics sales and marketing leader passionate about improving oncology healthcare delivery through the integration of genetic and genomic technologies. Liz excels at bringing internal and external stakeholders together to work towards shared goals and inspiring her teammates to achieve their greatest potential. Every day Liz's goal is to connect people, improve care and deliver better patient outcomes.
Currently, Liz leads a diagnostic oncology sales team of Clinical Oncology Specialists as a Regional Director at Natera Oncology. Natera's novel assay, Signatera, is the first and only patient-specific, custom-built circulating tumor DNA (ctDNA) monitoring assay available for clinical use. Signatera detects the presence or absence of circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer.
Previously as Regional Business Director, at Caris Life Sciences Liz led a team covering oncology practices and major NCI designated cancer centers within four states. Caris offers a comprehensive genomic profiling service for advanced cancer patients inclusive of Next-Generation DNA Sequencing, RNA Whole Transcriptome Sequencing, Proteomics, immunotherapy diagnostics and clinical trial matching.
An experienced go-to-market sales leader, Liz has launched 10+ oncology molecular diagnostics, oncology companion diagnostics, cancer genetic tests, medical devices and pharmaceuticals within sixteen years.
While at Myriad Genetic Laboratories, Liz challenged a 15 year old notion, spearheading an initiative that opened access to cancer genetic testing for over 8,000 underserved patients in Maryland.
Outside of industry, Liz served as an Executive member of the Founding Board of Directors of Breast Care for Washington (BCW). Ms. Cramer lead BCW's launch marketing strategy, developing BCW's online presence, to take the organization from a grassroots initiative to serving patients within two years. BCW's mission is to provide breast cancer screening and diagnostics to all women, regardless of ability to pay.
As part of the Rare Genomics Institute Scientific team, Liz served as a diagnostics life cycle marketing product manager, working with a team of PhD's to develop pre-launch strategy for rareREACH, an online database used to match patients with rare diseases with researchers, in hopes of a diagnosis and treatment.
Liz has a special interest in leveraging social media in healthcare. In 2012, Liz founded PUGTATO, a blog that focuses on trends in healthcare marketing and social media strategy. PUGTATO has been featured by patient communities, LinkedIn pulse channels and healthcare advertising agencies.
Liz holds an M.B.A. from the University of Maryland, and a B.A. in Economics from Bucknell University.
Naturally persuasive and articulate in presentation, I am an idea generator. Building a brand's identity, developing marketing messaging and compassionately understanding the needs of patients and providers in ways that improve healthcare value all energize me.
New Product Concept
Our team developed a new product concept and marketing strategy for Proportion Plate: an easy, fun, affordable way to manage obesity rates in the United States.
Designed as introduction collateral for Breast Care for Washington's launch. The BCW logo is designed by Amy Wajda of Takoma Design, takomadesign.com
BCW had a logo. What it didn't have was an icon or mascot the public could associate with. Enter the "Mammomobile" concept, which is now used as the flagship icon for the organization. Working with Amy Wajda, owner of Takoma Design, the mammomobile design was perfected.
Blueprinting customer service
Our team proposed changes to CVS pharmacy's service blueprint and a new marketing initiative, "CVS Clear"
EHR Adoption Rates
Master's level research performed to understand sluggish adoption rates and real world HCP perception.
Pick a subject. Make it interesting for readers.
Challenge the Status Quo
Challenge of a 15 year notion resulting in opened market access to Hereditary Cancer Genetic Testing for under-served patient communities in Maryland.
Early Trends & Warning Signals
Competitive landscape analysis for a large molecular diagnostic laboratory.
Big Pharma & Creativity
A deeper look into creativity killers in big pharma sales forces. Analysis to identify toxic behaviors and how to create a culture that encourages and demands creativity.
Remote and in-person cross functional work
Large and small clinical presentations at tumor boards, grand rounds and working groups
Develop online content relevant to stage in product life-cycle
Copywriting and design for community oncology practices
Write copy, develop messaging and create protocol for integration of Cancer Genetics High Risk Assessment Clinics in Oncology Service Lines
Use digital to form partnerships
Select platform and build out online rare disease patient case library used to connect patients receiving whole exome sequencing to potential researchers.